Stock Financial Ratios


ITRI / Itron, Inc. financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.

Valuation Metrics
Price66.00
Volume314,000.00
Market Cap ($M)2,592.98
Enterprise Value ($M)3,189.06
Book Value ($M)631.60
Book Value / Share16.34
Price / Book3.37
NCAV ($M)1,464.63
NCAV / Share37.90
Price / NCAV1.56
Income Statement (mra) ($M)
Revenue2,013.19
EBITDA96.21
Net Income35.05
Balance Sheet (mrq) ($M)
Cash & Equivalents137.58
Cash / Share3.56
Assets2,169.19
Liabilities1,027.42
Quick Ratio2.10
Current Ratio2.50
Management Effectiveness (mra)
Return on Invested Capital (ROIC)0.04
Return on Assets (ROA)0.02
Return on Equity (ROE)0.06
Identifiers and Descriptors
CUSIP465741106
Central Index Key (CIK)780571
Industry Groups
SIC 3825 - Instruments for Measuring and Testing of Electricity and Electrical Signals
Other Related CUSIPS
465741906
465741956
Share Statistics
Common Shares Outstanding (M)38.73
Scoring Models
Piotroski F Score7.00
Altman Z ScoreN/A
Beneish M ScoreN/A
Kaplan-Zingales KZ-IndexN/A
Cash Conversion CycleN/A
Per Share Metrics
Cash Per Share3.56
Inventory Work In Progress Per Share0.00
Property Plant And Equipment Net Per Share4.99
Additional Paid In Capital Per Share0.00
Treasury Stock Per Share0.00
Assets Other Current Per Share2.92
Intangibles Per Share2.60
Debt Per Share0.47
Current Portion Of Long Term Debt Per Share0.47
Assets Current Per Share30.68
Assets Per Share56.13
Liabilities Current Per Share12.90
Accounts Receivable Per Share9.09
Minority Interest Per Share0.52
Liabilities Per Share26.59
Long Term Debt Per Share7.87
Inventory Per Share5.37
Equity Per Share19.94
Cash And Equivalents Per Share3.56
Liabilities And Stock Equity Per Share47.04
Retained Earnings Per Share-8.79
Property Plant And Equipment Gross Per Share15.26
Goodwill Per Share14.25
Property Plant And Equipment Per Share4.99
Accumulated Depreciation And Depletion Per Share10.27
Inventory Raw Materials Per Share0.00
Liabilities Other Non Current Per Share2.89
Accounts Payable Per Share0.00
Inventory Finished Goods Per Share0.00
Preferred Stock Value Outstanding Per Share0.00
Assets Non Current Per Share0.00
Assets Other Non Current Per Share1.14
Deferred Income Tax Liabilities Per Share0.09

Related News Stories

Itron Extends SMECO Contract, Offers Outsourced Solution

2017-11-14 zacks
Itron, Inc. (ITRI - Free Report) recently extended its contract with Southern Maryland Electric Cooperative (SMECO) by three years to provide pay-for-performance demand-response solution. The partnership between Itron and SMECO enables the latter to offer reliable power and lower rates for its customers. Itron’s long-standing partnership with SMECO began in 2008, with the installation of more than 45,000 load-control devices for residential and small commercial customers under SMECO’s CoolSentry outsourced demand-response program. (58-0)

Itron, Inc. 2017 Q3 - Results - Earnings Call Slides

2017-11-06 seekingalpha
The following slide deck was published by Itron, Inc. in conjunction with their 2017 Q3 earnings call.

Itron (ITRI) Q3 Earnings & Revenues Lag on Shipment Delays

2017-11-04 zacks
Itron, Inc.’s (ITRI - Free Report) third-quarter 2017 adjusted earnings of 77 cents per share remained flat year over year. Earnings, however, missed the Zacks Consensus Estimate of 89 cents. Results bore the impact of delay in shipments due to short-term issues related to factory consolidation, supply chain transitions and ramped-up deliveries of new solutions. These steps were carried out by Itron in a bid to improve operational efficiencies and transform its business. (6-0)

Is Danaher Set to Beat Q3 Earnings on Life Sciences Growth?

2017-10-18 zacks
Danaher Corporation (DHR - Free Report) is scheduled to report third-quarter 2017 results before the opening bell on Oct 19. In the quarter to be reported, the company is expected to report strong revenues in Life Sciences & Diagnostics business, which constitutes more than half of its total revenues. (125-0)

Top Ranked Growth Stocks to Buy for October 13th

2017-10-13 zacks
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, October 13th: (134-0)

CUSIP: 465741106